X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21550) 21550
Book Review (3971) 3971
Publication (1415) 1415
Book Chapter (179) 179
Conference Proceeding (49) 49
Dissertation (22) 22
Government Document (13) 13
Newsletter (8) 8
Magazine Article (6) 6
Newspaper Article (3) 3
Journal / eJournal (2) 2
Paper (2) 2
Web Resource (2) 2
Book / eBook (1) 1
Data Set (1) 1
Presentation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
radical prostatectomy (17325) 17325
index medicus (15852) 15852
humans (15064) 15064
male (14376) 14376
prostate cancer (11623) 11623
urology & nephrology (9648) 9648
aged (7924) 7924
middle aged (7919) 7919
prostatic neoplasms - pathology (6050) 6050
oncology (5763) 5763
cancer (5616) 5616
prostatic neoplasms - surgery (4923) 4923
prostatectomy (4193) 4193
surgery (3473) 3473
prostate-specific antigen - blood (3260) 3260
men (3125) 3125
treatment outcome (2965) 2965
urology (2927) 2927
radiotherapy (2850) 2850
prognosis (2816) 2816
carcinoma (2757) 2757
care and treatment (2647) 2647
neoplasm staging (2471) 2471
aged, 80 and over (2443) 2443
prostate (2442) 2442
retrospective studies (2441) 2441
adult (2336) 2336
prostatic neoplasms - therapy (2328) 2328
prostatectomy - methods (2274) 2274
abridged index medicus (2261) 2261
prostatic neoplasms - diagnosis (2261) 2261
risk factors (2170) 2170
prostatic neoplasms - radiotherapy (2131) 2131
biopsy (2119) 2119
prostatic neoplasms - blood (2080) 2080
outcomes (2037) 2037
radiation-therapy (1958) 1958
research (1940) 1940
radiology, nuclear medicine & medical imaging (1883) 1883
analysis (1861) 1861
diagnosis (1839) 1839
survival (1793) 1793
risk (1774) 1774
prostatic neoplasms - mortality (1752) 1752
antigen (1703) 1703
health aspects (1689) 1689
prostate-specific antigen (1670) 1670
follow-up studies (1646) 1646
radical retropubic prostatectomy (1524) 1524
prostate - pathology (1519) 1519
quality-of-life (1500) 1500
adenocarcinoma (1476) 1476
mortality (1446) 1446
prostatic neoplasms (1446) 1446
recurrence (1404) 1404
prostatectomy - adverse effects (1363) 1363
progression (1358) 1358
quality of life (1348) 1348
therapy (1313) 1313
prospective studies (1280) 1280
medicine & public health (1272) 1272
time factors (1270) 1270
biochemical recurrence (1257) 1257
laparoscopy (1237) 1237
female (1176) 1176
disease-free survival (1164) 1164
neoplasm grading (1107) 1107
metastasis (1081) 1081
predictive value of tests (1078) 1078
follow-up (1064) 1064
brachytherapy (1028) 1028
management (1012) 1012
active surveillance (984) 984
prostatic neoplasms - drug therapy (980) 980
gleason score (969) 969
disease progression (961) 961
pathology (960) 960
experience (957) 957
erectile dysfunction (944) 944
risk assessment (917) 917
impact (912) 912
article (904) 904
patient outcomes (886) 886
oncology, experimental (884) 884
multivariate analysis (865) 865
usage (853) 853
complications (824) 824
tumors (817) 817
patients (812) 812
prostatic neoplasms - genetics (812) 812
prostatic neoplasms - metabolism (810) 810
retropubic prostatectomy (810) 810
magnetic resonance imaging (805) 805
sensitivity and specificity (798) 798
medicine, general & internal (795) 795
radiation therapy (791) 791
robotics (789) 789
robotic surgery (779) 779
survival rate (773) 773
androgen antagonists - therapeutic use (767) 767
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19564) 19564
French (748) 748
German (694) 694
Spanish (470) 470
Russian (117) 117
Japanese (63) 63
Turkish (34) 34
Hungarian (18) 18
Italian (18) 18
Portuguese (15) 15
Dutch (14) 14
Korean (11) 11
Chinese (7) 7
Polish (7) 7
Czech (6) 6
Lithuanian (3) 3
Swedish (3) 3
Slovak (2) 2
Croatian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Laparoscopic radical prostatectomy, 12/2005
Millions of men are diagnosed annually with prostate cancer worldwide. With the advent of PSA screening, there has been a shift in the detection of early... 
prostate cancer, laparoscopic prostatectomy, radical
Journal
BJU International, ISSN 1464-4096, 08/2016, Volume 118, Issue 2, pp. 302 - 306
Journal Article
BJU International, ISSN 1464-4096, 08/2015, Volume 116, Issue 2, pp. 230 - 235
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 70, Issue 5, pp. 846 - 853
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2017, Volume 23, Issue 9, pp. 2169 - 2176
Purpose: Prostate cancer is dependent on androgen receptor (AR) activation. Optimal AR antagonism may effectively cytoreduce local disease and suppress or... 
THERAPY | ANTIANDROGEN | ONCOLOGY | RESISTANCE | PHASE-II | RADICAL PROSTATECTOMY | INCREASED SURVIVAL | CANCER | CHEMOTHERAPY | PROGRESSION | ABIRATERONE | Neoplasm, Residual - pathology | Phenylthiohydantoin - adverse effects | Prostatic Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prostatic Neoplasms - surgery | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Combined Modality Therapy | Neoplasm, Residual - blood | Phenylthiohydantoin - analogs & derivatives | Prostate-Specific Antigen - blood | Phenylthiohydantoin - administration & dosage | Receptors, Androgen - genetics | Leuprolide - administration & dosage | Neoadjuvant Therapy - adverse effects | Prostatic Neoplasms - blood | Prostatectomy | Aged | Neoplasm, Residual - chemically induced | Dutasteride - administration & dosage | Prostatic Neoplasms - drug therapy | Therapy | Risk groups | Health risks | Minimal residual disease | Patients | Anticancer properties | Testosterone | Signaling | Dihydrotestosterone | Androgens | Flutamide | Experimental design | Luteinizing hormone | Luteinizing hormone-releasing hormone | Antitumor activity | Prostate cancer | Prostate | Cancer | Index Medicus | dutasteride | neoadjuvant | NEW MOLECULAR TARGETS | THERAPEUTICS: Cellular responses to anticancer drugs | CL01 PHASE I – III CLINICAL TRIALS: Phase I–III Trials_Genitourinary cancers: prostate | ET02 MECHANISMS OF DRUG ACTION | enzalutamide
Journal Article
The Journal of Urology, ISSN 0022-5347, 2003, Volume 169, Issue 6, pp. 2289 - 2292
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 2/2012, Volume 39, Issue 2, pp. 271 - 282
Journal Article
Journal Article